why choose us

First received: November 17, 2023

Clinical Trial: INcreased Sun Exposure Without Pain In Research Subjects With EPP

Study Status: Completed

Recruit Status: RECRUITING

Condition: Erythropoietic Protoporphyria (EPP)

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-L

Brief Summary: To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.

Read more